Global Cardiovascular Catheters Market to Grow at a CAGR of 7.4% by 2021: Analysis By Product & End User

DUBLIN, September 1, 2017 /PRNewswire/ --

The "Global Cardiovascular Catheters Market 2017-2021" report has been added to Research and Markets' offering.

The global cardiovascular catheters market is forecast to grow at a CAGR of 7.4% during the period 2017-2021.

The report, Global Cardiovascular Catheters Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The latest trend gaining momentum in the market is the increase in M&A. Vendors undergo M&A to extend their product offerings, increase their market shares, and expand their operations. They acquire other companies to enhance their R&D capabilities for manufacturing innovative devices that meet consumer needs. The acquisition allows vendors to access the product portfolio of the acquired company.

According to the report, one of the major drivers for this market is NHS health plans and EU insurance in UK. According to a study conducted by the Nuffield Department of Population Health, British Heart Foundation Centre on Population Approaches for Non-Communicable Disease Prevention, University of Oxford, UK in 2015, around 2.3 million people had CHD of which around 1.2 million people had a stroke, one million had AF, and 480,000 had heart failure. The EU provides European Health Insurance Card (EHIC), which provides access to the people to opt for healthcare provided by the state and country. If the procedure cost is less, then the card helps the patient to avail free of cost treatment.

Further, the report states that one of the major factors hindering the growth of this market is the high cost of angioplasty products and procedures. PCI procedures such as stenting include angioplasty balloon catheters, a stent, and embolic protection devices. To insert the balloon catheter along with the stent, cardiologist widens the arteries. An embolic protection device is used to close the artery after the procedure is done. The estimated cost associated with stenting ranges between $12,000 and $38,000, which includes the cost of products and procedure. In such cases, the estimated cost of the stents will be around $2,000-$4,000, and the estimated cost of DEB in the US ranges between $8,500 and $11,000.

Key vendors

• Boston Scientific
• St. Jude Medical
• C. R. Bard
• Medtronic

Other prominent vendors

• B. Braun Melsungen
• Balton
• Baylis Medical
• QT Vascular
• Shockwave Medical
• Others
  

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market Landscape

Part 06: Market Segmentation By Product

Part 07: Market Segmentation By End-User

Part 08: Geographical Segmentation

Part 09: Decision Framework

Part 10: Drivers And Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Key Vendor Analysis

Part 14: Appendix

For more information about this report visit https://www.researchandmarkets.com/research/779mbp/global

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716